RECOMBINANT HUMAN ERYTHROPOIETIN TREATMENT IN PATIENTS ON MAINTENANCE HOME HAEMODIALYSIS

The Lancet

Volumn 334, Issue 8662, 1989, Pages 569-

  Winearls, C G ^a   Forman, E ^a   Wiffen, P ^a   Oliver, D O ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; HOME DIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL;

ERYTHROPOIETIN; HEMODIALYSIS, HOME; HUMAN; RECOMBINANT PROTEINS; SELF ADMINISTRATION;

EID: 0024343442     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(89)90698-3     Document Type: Letter

References (4)

1. Effect of human erythropoietin denved from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
2. Blood pressure and erythropoietin
3. Blood pressure and erythropoietin
4. Benefits and risk of protracted treatment with recombinant human eruthropoietin in patients having haemodialysis